IDEAYA Biosciences (IDYA) Change in Receivables (2021 - 2024)
IDEAYA Biosciences' (IDYA) quarterly Change in Receivables came in at -$2000.0 in Q4 2024, up 99.97% year-on-year from -$1000.1 in Q1 2024, and down 110.53% quarter-over-quarter from $19000.0 in Q3 2024.
IDEAYA Biosciences (IDYA) Change in Receivables (2021 - 2024) Analysis & Trends
IDEAYA Biosciences has disclosed Change in Receivables across 4 years of filings, most recently posting -$2000.0 for Q4 2024.
- Change in Receivables for Q4 2024 came in at -$2000.0, up 99.97% year-over-year; the trailing twelve-month figure through Sep 2024 was -$6.7 million (down 305.38% YoY), and the FY2023 annual result was -$193000.0, up 78.36% from the prior year.
- Change in Receivables came in at -$2000.0 for Q4 2024 at IDEAYA Biosciences, down from $19000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $6.5 million in Q3 2023 to a low of -$6.7 million in Q4 2023.
- The 4-year median for Change in Receivables is -$8500.0 (2024), against an average of -$116187.5.
- Peak annual rise in Change in Receivables reached 1129.64% in 2022, while the deepest fall reached 3909.41% in 2022.
- IDEAYA Biosciences' Change in Receivables stood at $85000.0 in 2021, then slumped by 3909.41% to -$3.2 million in 2022, then sank by 106.45% to -$6.7 million in 2023, then jumped by 99.97% to -$2000.0 in 2024.
- The last three Change in Receivables figures came in at -$2000.0 (Q4 2024), $19000.0 (Q3 2024), and -$14000.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | IDEAYA Biosciences | 2.78 Bn | 2.10 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Jun 30, 2024 | -14,000.00 |
| Jun 30, 2024 | -14,000.00 |
| Mar 31, 2024 | -3,000.00 |
| Mar 31, 2024 | -3,000.00 |
| Dec 31, 2023 | -6.69 Mn |
| Dec 31, 2023 | -6.69 Mn |
| Sep 30, 2023 | 6.54 Mn |
| Sep 30, 2023 | 6.54 Mn |
| Jun 30, 2023 | -308,000.00 |
| Jun 30, 2023 | -308,000.00 |
| Mar 31, 2023 | 257,000.00 |
| Mar 31, 2023 | 257,000.00 |
| Dec 31, 2022 | -3.24 Mn |
| Dec 31, 2022 | -3.24 Mn |
| Sep 30, 2022 | 3.16 Mn |
| Sep 30, 2022 | 3.16 Mn |